These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells. De Salvo M; Raimondi L; Vella S; Adesso L; Ciarapica R; Verginelli F; Pannuti A; Citti A; Boldrini R; Milano GM; Cacchione A; Ferrari A; Collini P; Rosolen A; Bisogno G; Alaggio R; Inserra A; Locatelli M; Stifani S; Screpanti I; Miele L; Locatelli F; Rota R PLoS One; 2014; 9(5):e96238. PubMed ID: 24797362 [TBL] [Abstract][Full Text] [Related]
4. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines. Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930 [TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I has different effects on myogenin induction and cell cycle progression in human alveolar and embryonal rhabdomyosarcoma cells. Tsuchiya K; Hosoi H; Misawa-Furihata A; Houghton PJ; Sugimoto T Int J Oncol; 2007 Jul; 31(1):41-7. PubMed ID: 17549403 [TBL] [Abstract][Full Text] [Related]
6. Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence. Li JJ; Kovach AR; DeMonia M; Slemmons KK; Oristian KM; Chen C; Linardic CM Sci Rep; 2021 Aug; 11(1):16505. PubMed ID: 34389744 [TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid. Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481 [TBL] [Abstract][Full Text] [Related]
8. Selective regulation of multidrug resistance protein in vascular smooth muscle cells by the isoquinoline alkaloid coptisine. Suzuki H; Tanabe H; Mizukami H; Inoue M Biol Pharm Bull; 2010; 33(4):677-82. PubMed ID: 20410605 [TBL] [Abstract][Full Text] [Related]
9. GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis. Srivastava RK; Kaylani SZ; Edrees N; Li C; Talwelkar SS; Xu J; Palle K; Pressey JG; Athar M Oncotarget; 2014 Dec; 5(23):12151-65. PubMed ID: 25432075 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice. van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124 [TBL] [Abstract][Full Text] [Related]
11. Cetuximab promotes immunotoxicity against rhabdomyosarcoma in vitro. Herrmann D; Seitz G; Warmann SW; Bonin M; Fuchs J; Armeanu-Ebinger S J Immunother; 2010 Apr; 33(3):279-86. PubMed ID: 20445348 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxicity evaluation of 13-n-alkyl berberine and palmatine analogues as anticancer agents. Zhang L; Li J; Ma F; Yao S; Li N; Wang J; Wang Y; Wang X; Yao Q Molecules; 2012 Sep; 17(10):11294-302. PubMed ID: 23011273 [TBL] [Abstract][Full Text] [Related]
13. Close correlation between CXCR4 and VEGF expression and frequent CXCR7 expression in rhabdomyosarcoma. Miyoshi K; Kohashi K; Fushimi F; Yamamoto H; Kishimoto J; Taguchi T; Iwamoto Y; Oda Y Hum Pathol; 2014 Sep; 45(9):1900-9. PubMed ID: 25086956 [TBL] [Abstract][Full Text] [Related]
18. Synergistic inhibition on acetylcholinesterase by the combination of berberine and palmatine originally isolated from Chinese medicinal herbs. Mak S; Luk WW; Cui W; Hu S; Tsim KW; Han Y J Mol Neurosci; 2014 Jul; 53(3):511-6. PubMed ID: 24793543 [TBL] [Abstract][Full Text] [Related]
19. Effects of standard chemotherapy on tumor growth and regulation of multidrug resistance genes and proteins in childhood rhabdomyosarcoma. Seitz G; Warmann SW; Vokuhl CO; Heitmann H; Treuner C; Leuschner I; Fuchs J Pediatr Surg Int; 2007 May; 23(5):431-9. PubMed ID: 17211591 [TBL] [Abstract][Full Text] [Related]
20. Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells. Beccafico S; Morozzi G; Marchetti MC; Riccardi C; Sidoni A; Donato R; Sorci G Carcinogenesis; 2015 Sep; 36(9):1071-83. PubMed ID: 26153023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]